Tividenofusp alfa (tividenofusp alfa-eknm; AVLAYAH™) is an intravenous brain-penetrant enzyme replacement therapy being developed by Denali Therapeutics for the treatment of mucopolysaccharidosis type II (MPS II). Also known as Hunter syndrome, MPS II is a ra... ...
